教育经历：

　　2002–2005年，中国科学院上海药物研究所，研究生/理学博士学位

　　1999–2002年，新疆医科大学药理室，研究生/医学硕士学位

　　1992–1997年，新疆医科大学临床医学院，本科/医学学士学位

工作经历：

　　2005.07–至今，中国科学院上海药物研究所

　　1997.09–2002.07，新疆医科大学药理室 教师

针对难治性自身免疫性疾病（银屑病、炎症性肠病、慢性肾炎等）和病毒感染性疾病开展创新药物的发现和基础研究。

中华预防医学会生物安全与防护装备分会青年委员会，常务委员

中国药理学会抗炎免疫药理学专委会，委员

中国药理学会肾脏药理专业委员会，委员

1. Artemisinin analogue SM934 attenuate collagen-induced arthritis by suppressing T follicular helper cells and T helper 17 cells. Scientific Reports. 2016 in press.

2. A novel pyridazinone derivative inhibits hepatitis B virus replication by inducing genome-free capsid formation. Antimicrob Agents Chemother. 2015 Nov;59(11):7061-72.

3. Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation. Cellular & molecular immunology. 2015, 1-12.

4. Benzimidazole Derivative, BM601, a Novel Inhibitor of Hepatitis B Virus and HBsAg Secretion. Antiviral Res. 2014 Apr 15;107C:6-15.

5. Therapeutic effects of DZ2002, a reversible SAHH inhibitor, on lupus-prone NZB×NZW F1 mice via interference with TLR-mediated APC response. Acta Pharmacol Sin. 2014 Feb;35(2):219-29.

6. Artemisinin Analogue SM934 Ameliorates Murine Experimental Autoimmune Encephalomyelitis through Enhancing the Expansion and Functions of Regulatory T Cell. PLoS One. 2013 Aug 29;8(8):e74108.

7. Structure-Based Design and Synthesis of C-1- and C-4-Modified Analogs of Zanamivir as Neuraminidase Inhibitors. J Med Chem. 2013 Feb 14;56(3):671-84.

8. Synthesis of C-4-modified zanamivir analogs as neuraminidase inhibitors and their anti-AIV activities. Eur J Med Chem. 2012 Aug;54:764-70.